| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gregory A. Poland | Q22096751 |
| Inna G Ovsyannikova | Q88569357 | ||
| P2093 | author name string | Jennifer A Whitaker | |
| P2860 | cites work | The Age-Old Struggle against the Antivaccinationists | Q22248117 |
| Genome-wide association study of antibody response to smallpox vaccine | Q24612100 | ||
| Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics | Q24648874 | ||
| The Xs and Y of immune responses to viral vaccines | Q24706476 | ||
| Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants | Q27025757 | ||
| Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization? | Q27478400 | ||
| Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination | Q27487839 | ||
| Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity | Q27650811 | ||
| Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus | Q27667750 | ||
| Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire | Q27679355 | ||
| Immune self-reactivity triggered by drug-modified HLA-peptide repertoire | Q27681301 | ||
| Proof of principle for epitope-focused vaccine design | Q27681593 | ||
| The IL-4 receptor: signaling mechanisms and biologic functions | Q28198739 | ||
| Genetic variations in HLA-B region and hypersensitivity reactions to abacavir | Q28214097 | ||
| The clinician's guide to the anti-vaccinationists' galaxy | Q28264526 | ||
| Risk of intussusception after monovalent rotavirus vaccination | Q46186510 | ||
| Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population | Q46308038 | ||
| Personalized vaccinology: one size and dose might not fit both sexes | Q46593394 | ||
| Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy | Q48344918 | ||
| Etiologies for seizures around the time of vaccination. | Q50632230 | ||
| Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults. | Q50969746 | ||
| Immunogenicity of a recombinant hepatitis B vaccine in adults. | Q50997267 | ||
| Vaccinomics, predictive vaccinology and the future of vaccine development. | Q51772775 | ||
| Pharmacology, vaccinomics, and the second golden age of vaccinology. | Q53169887 | ||
| The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg. | Q53906107 | ||
| Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population. | Q54454543 | ||
| De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. | Q54600675 | ||
| The contribution of HLA class I antigens in immune status following two doses of rubella vaccination | Q57157974 | ||
| Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine | Q57158024 | ||
| Vaccine safety--vaccine benefits: science and the public's perception | Q77797870 | ||
| Association between IL-4 genotype and IL-4 production in the Japanese population | Q77962121 | ||
| Concurrent HLA-related response factors mediate recombinant hepatitis B vaccine major adverse events | Q80417834 | ||
| Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome | Q80969155 | ||
| Fc receptor like 3 in Chinese patients of Han nationality with Guillain-Barré syndrome | Q83766486 | ||
| Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barré syndrome | Q84520400 | ||
| Vaccidents and adversomics | Q85013463 | ||
| Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination | Q86370806 | ||
| Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses | Q44211857 | ||
| Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors | Q44241974 | ||
| Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. | Q44311902 | ||
| Cytokine profiling in abacavir hypersensitivity patients. | Q44668954 | ||
| Immunology. Key narcolepsy-influenza vaccine findings retracted | Q45189413 | ||
| Parental vaccine refusal in Wisconsin: a case-control study. | Q46105607 | ||
| The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed | Q28391462 | ||
| The ontology of genetic susceptibility factors (OGSF) and its application in modeling genetic susceptibility to vaccine adverse events | Q28657755 | ||
| AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland | Q28730881 | ||
| Adverse events associated with smallpox vaccination in the United States, January-October 2003. | Q30231595 | ||
| Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel | Q30310967 | ||
| Sex-based biology and the rational design of influenza vaccination strategies. | Q30363998 | ||
| Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. | Q30369654 | ||
| Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland | Q30414919 | ||
| Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines | Q30626750 | ||
| Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data | Q31109981 | ||
| Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia | Q33395660 | ||
| Gender effects on humoral immune responses to smallpox vaccine | Q33701473 | ||
| Adversomics: the emerging field of vaccine adverse event immunogenetics | Q33744268 | ||
| Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology | Q33814924 | ||
| Genetic factors in immunity and aging | Q33846318 | ||
| Ten great public health achievements--United States, 1900-1999. | Q33860005 | ||
| Understanding those who do not understand: a brief review of the anti-vaccine movement. | Q33938837 | ||
| Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir | Q33956146 | ||
| Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. | Q33986805 | ||
| Adverse event reports following yellow fever vaccination | Q34013868 | ||
| HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study | Q34024252 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 | ||
| Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977 | Q34215590 | ||
| Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals | Q34221463 | ||
| Genome-wide genetic associations with IFNγ response to smallpox vaccine | Q34221936 | ||
| Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease | Q34330690 | ||
| How society should respond to the risk of vaccine rejection | Q34354032 | ||
| Guillain-Barré syndrome following influenza vaccination | Q34370829 | ||
| Biological challenges and technological opportunities for respiratory syncytial virus vaccine development | Q34504791 | ||
| Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study | Q34535561 | ||
| HLA-B*5701 screening for hypersensitivity to abacavir | Q34747145 | ||
| Immune response during adverse events after 17D-derived yellow fever vaccination in Europe | Q34770828 | ||
| Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections | Q35193959 | ||
| The link between rotavirus vaccination and intussusception: implications for vaccine strategies | Q35594270 | ||
| Smallpox vaccine: problems and prospects | Q35643944 | ||
| Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013 | Q35661817 | ||
| Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination | Q35731350 | ||
| Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine | Q35821331 | ||
| The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program | Q36065372 | ||
| Public fear of vaccination: separating fact from fiction | Q36202971 | ||
| Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination | Q36295858 | ||
| Narcolepsy with cataplexy | Q36733271 | ||
| Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed | Q36970735 | ||
| Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics | Q36986515 | ||
| Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes | Q37073520 | ||
| Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century | Q37119456 | ||
| Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine | Q37158293 | ||
| Application of pharmacogenomics to vaccines | Q37293663 | ||
| Genetic basis for adverse events after smallpox vaccination | Q37351650 | ||
| Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant | Q37356747 | ||
| Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations | Q37439385 | ||
| Mapping vaccine hesitancy--country-specific characteristics of a global phenomenon. | Q37706821 | ||
| Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? | Q37733972 | ||
| Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use. | Q38135977 | ||
| Addressing the anti-vaccination movement and the role of HCWs. | Q38164899 | ||
| Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. | Q38193651 | ||
| Childhood vaccination associated adverse events by sex: a literature review | Q38200356 | ||
| Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older | Q38380921 | ||
| The immunogenetics of smallpox vaccination. | Q40447133 | ||
| Effect of gender on reporting of MMR adverse events in Saudi Arabia. | Q40465589 | ||
| Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. | Q40533713 | ||
| Gender differences in the reactogenicity of measles-mumps-rubella vaccine | Q40623009 | ||
| Identification of an association between HLA class II alleles and low antibody levels after measles immunization | Q40680106 | ||
| Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies | Q40961043 | ||
| Neuroimmunology: Disease mechanisms in narcolepsy remain elusive | Q42183773 | ||
| Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. | Q42205327 | ||
| Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human | Q42217708 | ||
| A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations | Q42252783 | ||
| Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. | Q42263245 | ||
| Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study | Q43823253 | ||
| Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus | Q43852460 | ||
| Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses | Q43943522 | ||
| Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. | Q44106887 | ||
| P433 | issue | 7 | |
| P921 | main subject | vaccine engineering | Q14861085 |
| vaccine safety | Q105256838 | ||
| P304 | page(s) | 935-947 | |
| P577 | publication date | 2015-05-02 | |
| P1433 | published in | Expert Review of Vaccines | Q15756339 |
| P1476 | title | Adversomics: a new paradigm for vaccine safety and design | |
| P478 | volume | 14 |
| Q88979121 | Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression |
| Q47312985 | Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15. |
| Q88185334 | Authors' reply: Safety of Human Papillomavirus Vaccines |
| Q91742889 | Causality assessment of adverse events following immunization: the problem of multifactorial pathology |
| Q97519043 | Current Challenges in Vaccinology |
| Q41928069 | Early molecular correlates of adverse events following yellow fever vaccination |
| Q40107665 | Personalized vaccinology: A review |
| Q61657889 | SleepOMICS: How Big Data Can Revolutionize Sleep Science |
| Q47262746 | The use of databases, data mining and immunoinformatics in vaccinology: where are we? |
| Q59137099 | Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action |
| Q51416013 | Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview. |
| Q24261399 | Vaccinology in the third millennium: scientific and social challenges |
Search more.